Inhibitor of Differentiation 1 (ID1) Facilitates the Efficacy of Sorafenib in Non-Small Cell Lung Cancer Cells through Suppressing Epithelial to Mesenchymal Transition.

Zhao, Yu-Xiao; Liu, Jian

Zhao, Yu-Xiao; Liu, Jian.

Affiliation

Zhao YX; Queen Mary School, Nanchang University, Nanchang, Jiangxi, China (mainland).
Liu J; Department of Emergency Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland).

Med Sci Monit ; 26: e922148, 2020 Apr 10.

Article in En | MEDLINE | ID: mdl-32275644

Subject(s)

Carcinoma, Non-Small-Cell Lung/pathology; Epithelial-Mesenchymal Transition/drug effects; Inhibitor of Differentiation Protein 1/metabolism; Protein Kinase Inhibitors/pharmacology; Sorafenib/pharmacology; Carcinoma, Non-Small-Cell Lung/drug therapy; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic/drug effects; Humans; RNA Interference; RNA, Small Interfering

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Inhibitor of Differentiation Protein 1 / Epithelial-Mesenchymal Transition / Sorafenib Limits: Humans Language: En Journal: Med Sci Monit Journal subject: MEDICINA Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google